LIC divests 2.011% stake, decreasing its shareholding to 3.012% in Sun Pharma
The sale occurred between July 22 and September 13 at an average price of Rs 973.80 per share
Sun Pharma reported a slight dip in net profit for Q2 2023 compared to the previous year
Earlier, LIC also reduced its stake in Dr. Reddy's Laboratories from 9.681% to 7.628%
The Dr. Reddy's stake reduction was conducted through open market transactions with an average floor price of Rs 5705.43 apiece
LIC's recent actions reflect a shift in its investment portfolio within the pharmaceutical industry